CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa™, a biomarker discovery company that enables personalized healthcare through stratification of patients based on disease-driving mechanisms, today announced that the U.S. Patent & Trademark Office has issued the Company U.S. Patent No 8,802,109, titled “Computer-aided Discovery of Biomarker Profiles in Complex Biological Systems.” This patent, which was issued on December 20, 2011, relates to methods and techniques that facilitate discovery of biomarkers and thus aid in the development of predictive and prognostic diagnostic tests for therapeutics targeting complex multi-factorial diseases.
